InvestorsHub Logo
Followers 4
Posts 586
Boards Moderated 0
Alias Born 07/07/2016

Re: Lorie3168 post# 77350

Saturday, 10/01/2016 2:02:45 PM

Saturday, October 01, 2016 2:02:45 PM

Post# of 698701
I don't think it is that clear...what is clear is that there is a favourable bias for mensenchymal subtype but I would definitly not rule out efficacy on other patients.
It is also probable that they have tried to screen as many mesenchymal as possible since that find. We will see once all that stuff is unblinded.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News